Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial

To evaluate whether the addition of hydrochlorothiazide (HCTZ) to intravenous furosemide is a safe and effective strategy for improving diuretic response in acute heart failure (AHF). A prospective, double-blind, placebo-controlled trial, including patients with AHF randomized to receive HCTZ or pla...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European heart journal 2023-02, Vol.44 (5), p.411-421
Hauptverfasser:	Trulls, Joan Carles, Morales-Rull, Jos Luis, Casado, Jess, Carrera-Izquierdo, Margarita, Snchez-Marteles, Marta, Conde-Martel, Alicia, Dvila-Ramos, Melitn Francisco, Llcer, Pau, Salamanca-Bautista, Prado, Prez-Silvestre, Jos, Plasn, Miguel Ngel, Cerqueiro, Jos Manuel, Gil, Paloma, Formiga, Francesc, Manzano, Luis
Format:	Artikel
Sprache:	eng
Schlagworte:	Diuretics - adverse effects Diuretics - therapeutic use Dyspnea Female Furosemide - therapeutic use Heart Failure Humans Hydrochlorothiazide - therapeutic use Hypokalemia - chemically induced Hypokalemia - complications Prospective Studies Sodium Chloride Symporter Inhibitors - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!